{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:09:06Z","timestamp":1648613346417},"reference-count":0,"publisher":"Index Copernicus","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol Przegl Chir"],"published-print":{"date-parts":[[2020,3,3]]},"abstract":"<jats:p>Introduction: Skin melanoma is estimated for 2% of malignant neoplasms occurring in humans. It is characterized by a high\nlevel of malignancy and low sensitivity to cytostatic drugs. The incidence of skin melanoma increases in Poland. Lymphatic\nsystem is the most common route of dissemination of this neoplasm. The appearance of a sentinel node biopsy technique\nhas made it possible to identify patients with a regionally advanced disease. It is a minimally invasive method with a small\npercentage of complications.\nAim: Analysis of disease free survival (DFS) in cutaneous melanoma patients with sentinel lymph node biopsy.\nMaterial and methods: The analysis included 222 patients with cutaneous melanoma treated in the Department of\nOncological Surgery in 2010\u20132015, who underwent a sentinel node biopsy. The study group consisted of 136 women and 86\nmen, the average age of patients was 59 years. Patients were qualified for sentinel node biopsy based on clinical evaluation\nand ultrasound of regional lymph nodes. The average follow-up was 25.1 months. About 2 hours before surgery, patients\nreceived the radioisotope, then lymphoscintigraphy SPECT was performed. Additionally, they got the Patent Blue dye in the\noperating room.\nResults: The sentinel node was identified in 217 patients (98%), and the average sentinel sentinel nodes were 2.25. 27 patients\n(12%) had the metastasis in sentinel nodes. In this group, the duration of asymptomatic survival was significantly shorter.\nSentinel node status and age of the patient were independent factors affecting the prognosis of disease free survival.\nConclusions: Sentinel node biopsy is a precise method to identify patients with skin melanoma who have metastasis to\nregional lymph nodes and the most important prognostic factor.\n\n<\/jats:p>","DOI":"10.5604\/01.3001.0013.9041","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:44:35Z","timestamp":1585921475000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of disease free survival in cutaneous melanoma patients with sentinel lymph node biopsy"],"prefix":"10.5604","volume":"92","author":[{"given":"Wojciech","family":"\u0141obaziewicz","sequence":"first","affiliation":[{"name":"Centrum Onkologii, Instytut im. Marii Sk\u0142odowskiej-Curie, Oddzia\u0142 w Krakowie, Klinika Chirurgii Onkologicznej, Krak\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Szloch","sequence":"additional","affiliation":[{"name":"Centrum Onkologii, Instytut im. Marii Sk\u0142odowskiej-Curie, Oddzia\u0142 w Krakowie, Klinika Chirurgii Onkologicznej, Krak\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Wajda","sequence":"additional","affiliation":[{"name":"Centrum Onkologii, Instytut im. Marii Sk\u0142odowskiej-Curie, Oddzia\u0142 w Krakowie, Klinika Chirurgii Onkologicznej, Krak\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr","family":"Legkiy","sequence":"additional","affiliation":[{"name":"Centrum Onkologii, Instytut im. Marii Sk\u0142odowskiej-Curie, Oddzia\u0142 w Krakowie, Klinika Chirurgii Onkologicznej, Krak\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Marczyk","sequence":"additional","affiliation":[{"name":"Centrum Onkologii, Instytut im. Marii Sk\u0142odowskiej-Curie, Oddzia\u0142 w Krakowie, Klinika Chirurgii Onkologicznej, Krak\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Wysocki","sequence":"additional","affiliation":[{"name":"Centrum Onkologii, Instytut im. Marii Sk\u0142odowskiej-Curie, Oddzia\u0142 w Krakowie, Klinika Chirurgii Onkologicznej, Krak\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","container-title":["Polish Journal of Surgery"],"original-title":[],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T10:20:25Z","timestamp":1587378025000},"score":1,"resource":{"primary":{"URL":"https:\/\/ppch.pl\/gicid\/01.3001.0013.9041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4,16]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0013.9041","relation":{},"ISSN":["0032-373X","2299-2847"],"issn-type":[{"value":"0032-373X","type":"print"},{"value":"2299-2847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]}}}